Anthony Letai, Director of the National Cancer Institute, shared on X:
“Every genetic variant tells a story – but until now, the risk associated with many BRCA2 variants has remained uncertain.
New research from National Cancer Institute classified more than 6,500 BRCA2 variants, helping lay the groundwork for more informed risk assessment.”
Other articles featuring Anthony Letai on OncoDaily.